A ten year study of management of chronic heart failure in a tertiary hospital in the South West Nigeria

International Journal of Pharmacy and Technology

Volumn 3, Issue 1, 2011, Pages 1520-1536

  Omole, Omole ^a   Ogunbayo, Olufunke O ^a   Fasanmade, Adesoji A ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Chronic heart failure; Management; Patients; Pharmacotherapy; Side effects

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORPHENIRAMINE MALEATE; DIAZEPAM; DIGOXIN; ENALAPRIL; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; FRUMIL; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOOP DIURETIC AGENT; METHYLDOPA; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; RAMIPRIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; CONTROLLED STUDY; COUGHING; DRUG TOLERABILITY; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NIGERIA; OUTPATIENT; PHARMACEUTICAL CARE; REVIEW; TERTIARY HEALTH CARE; TINNITUS;

EID: 79953879793     PISSN: None     EISSN: 0975766X     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Paul E., Nolan Jr. and Dawn G. Zarembski (2000). Congestive Heart Failure In Text Book of Therapeutics - Drug and Disease Management, Harfindale and Gouley 7: 825-866.
2. th Ed. 486-528.
3. Consensus Recommendations for the Management of Congestive Heart Faiure (1999) Part I, Evaluation of Heart Failure. Am J. Cardiol, 83 (Suppl A): 2A-8A.
4. Fonarow GC, Yancy CW, Chang SF (2003). Variation in heart failure quality of care indicators among us hospitals: analysis of 230 hospitals in ADHERE, Circulation 108: 447.
5. Pook-Wilson (1993) Relation of Pathophysiologic Mechanisms to outcome in heart failure. J A M College Cardiol 22 (Supp A) 22A-29A.
6. Baker D W, Koristam M. A., Bottorff M., Pitt B (1994). Management of Heart Failure J. Pharmacologio treatment JAMA 272: 1361-1366.
7. th Ed. Boston Little Brown 114.
8. Dracup, K; Baker D. W, Durbar S. B. Dancey R A. et al (1994) Management of Heart Failure in Counselling Education and Life Style Modifications. JAMA 272: 1442-1446.
9. European guidelines for the diagnosis and treatment of chronic heart failure (2001) European Heart J. 22: 1327-66.
10. Coats A. J. (1998) is preventive medicine responsible for the increasing prevalence of heart failure? Lancet 352 (Suppl) 39-41.
11. Fleg J L. Hinton P C, Lakatta E G, Marcus F L et al (1989). Physicians ultilization of laboratory procedures to monitor out patients with Congestive Heart Failure. Arch Inter Med 149: 393-396.
12. Self T. Soberman JE, Bubla JM, Chafin CC (2003). Cardioselective beta blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweight risks? J. Asthma 2003, 40: 839-845
13. Salpeter SR, Ormiston TM, Salpeter EE (2002). Cardioselective beta blockers in patients with reactive airway disease: a meta analysis. Am Intern med 137: 715-725
14. O'Connel J B, Briston M R. (1994). Economic Impact of Heart Failure in the United States - Times for a different approach J. Heart, Lung Transplant 13: 107-112.
15. Eichhorn E. J. Hjalmarsom A (1994). B-Blocker treatment for chronic heart failure the frog prince. Circulation 90: 2153-2156.
16. Pfeffer MA, McMurray JJV, Velasartan EJ, et al (2003). Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N. Engl J. med 349, 1892-1906.
17. Felker GM, Leim berger JD, califf RM et al (2004). Risk stratification after hospitalization for decomposed heart failure: J. card fail 10: 460-466.
18. Zerembski D. G. Nolati P. E., Slack M. K. Lui C Y, Meta-analysis of the use of low dose-adrenergic blocking therapy in idiopathic and ischemic cardiomyopathy. Am J. Cardiol (inpress).
19. Tsuyuki R. T., Avezum A. Yusuf S, (1995). B-blocker therapy for Congestive Heart Failure; a systematic overview (updated) abstract). Paper presented at the Annual meeting of the American College of Clinical Pharmacy, Washington DC. August 6-9.
20. Elkayam U, Sholan A, Mehra A, Ostrzega E. (1998). Calcium Channel Blockers in heart failure. J Am Coll Cardiol 22 (Suppl A) 139 A-144 A.
21. Scognamiglio R, Rahimtoola S H, Fasoli G, Nastri S, Volta S D. (1994). Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function N Eng J. Med 331: 689-694.
22. Helen Williams, Mark Kearney. (2002). Chronic Heart Failure. The Pharmaceutical Journal 269: 325-327.
23. Abraham WT, Hayes DL (2003). Cardiac resynchronization therapy for heart failure. Circulation 108: 2596-2960.
24. Consensus Recommendations for the Management of Heart (1999). Chronic Heart failure. Part II: management of heart failure: Am J cardiol 83 (Supp A) 9A-30A.
25. Bakris GL, Weir MR (2000) ACE inhibitor associated elevations in serum creatinine: is this a cause for concern? Arch Intern med 160: 685-693.
26. Rothlisberger C, Sareli P, Wisenbaugh T (1994) Comparison of a single dose Nifedipine and Captopril for Chronic Severe Mitral Regurgitation Am. J. Cardiol 73: 978-981.
27. Feenstra J. Grobbee D E., Remme W. J. et al (1999) Drug induced Heart Failure. J Am College Cordiol 33: 1152-1162.
28. Heerdink E. R. Leufkens H. G., Herings RM et al (1998) NSAIDS associated with increased risk of Cognestive Heart Failure in Elderly Patients taking Diuretics. Arch Intern Med 158: 1108-1112.